TNFRSF4 and neoplasm: In T cells, activation of OX40 signaling boosts antitumor effects by enhancing immune responses, whereas in tumor ECs, the activation of OX40 signaling induces EndMT by regulating YAP nuclear translocation and promoting angiogenesis, thereby exerting protumor effects.